- Clinical Hypnosis in Pediatric Crohn’s Disease
- Clinical Study of TA-650 in Pediatric Patients With Crohn’s Disease
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn’s Disease
- Exercise Training in Youth With Inflammatory Bowel Disease
- FMT in Pediatric Crohn’s Disease
- Low Dose Oral Methotrexate in Pediatric Crohn’s Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
- Mission is Remission®: How Can a Disease Self-management Website Change Care?
- Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
- PediCRaFT: Pediatric Crohn’s Disease Fecal Transplant Trial
- Peer Mentoring to Improve Self-management in Youth With IBD
- Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn’s Disease (CD)
- Post-Marketing Surveillance of Humira in Korean Pediatric Crohn’s Disease (CD) Patients Under the “New-Drug Re-examination”
- TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn’s Disease
- Trial of Enhanced Pre-Consent Discussion
- Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn’s Disease Pediatric Patients
Clinical Trials
- ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
- ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study
- Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes
- Cognitive Impairment in Pediatric Onset Multiple Sclerosis
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
- Exercise Training in Pediatric-Onset Multiple Sclerosis Patients
- Mobile Attentional Bias Modification Training in Pediatric MS
- Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis
- 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma
- A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy
- A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
- A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy
- A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
- A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
- A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma
- A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-Ew) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
- A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
- A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
- A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
- A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
- A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
- A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
- A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
- A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
- A Randomised Placebo-Controlled Study of Use of GnRHa During Chemotherapy for Fertility Protection of Young Women With Cancer
- A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX
- A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
- A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
- A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery
- A Study of Pemetrexed in Children With Recurrent Cancer
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
- A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
- A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
- A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma
- A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
- A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing’s Sarcoma (MK-7454-002/P04720)
- A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
- A Vaccine Study for High Risk Cancers
- ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
- ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
- Accuracy of Deep-learning Algorithm for Detection and Risk Stratification of Lung Nodules
- Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
- Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
- Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
- Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors
- Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
- Assessing Clinical Trial Experiences of Patients With Osteosarcoma
- Assessing Clinical Trial Outcome of Patients With Relapsed/Refractor Metastatic Osteosarcoma in Adolescents and Adults
- Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
- Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)
- Biology of Osteosarcoma (BOOST) Registry and Biobank
- Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
- Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
- Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
- BLESSED: Expanded Access for DeltaRex-G for Advanced Pancreatic Cancer and Sarcoma
- Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
- Cabozantinib With Topotecan-Cyclophosphamide
- Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS
- CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Chemotherapy for Patients With Osteosarcoma
- Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
- Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
- Clinical Orthopaedic Data Bank (Acute and Chronic)
- Clinical Studies of Gemcitabine-Oxaliplatin
- Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
- Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma
- Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
- Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
- Combination Immunotherapy Targeting Sarcomas
- Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
- Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
- Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
- Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma
- Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
- Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
- Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
- Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma
- Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
- Diffusion Study on Patients With Osteosarcoma
- Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
- Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
- DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
- Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
- Early Ageing in AYA Cancer Patients
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
- Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma
- Efficacy of Exercise Program on Osteosarcoma Patients
- Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients
- Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
- Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
- Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma
- European Study in Bone Sarcoma Patients Over 40 Years
- Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
- Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
- Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
- Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma
- Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
- Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
- Genetic Characterisation of High-grade Paediatric Osteosarcomas
- Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
- Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
- Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
- HGS-ETR2 to Treat Children With Solid Tumors
- HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
- High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
- Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
- Huntsman Biopsy Study
- IBI188 Combination Therapy in Solid Tumors
- ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
- Immunotherapy for Recurrent Osteogenic Sarcoma
- Informed Consent in Pediatric Cancer Trials
- Inheritance of Osteosarcoma & Paget’s Disease Through Chromosome 18:
- Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
- Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
- LN-145 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
- Long-Term Follow-Up of Patients Who Have Participated in Children’s Oncology Group Studies
- Losartan + Sunitinib in Treatment of Osteosarcoma
- M6620 (VX-970) in Selected Solid Tumors
- Markers of Anthracycline-Related Cardiac Muscle Injury
- Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
- Methionine PET/CT Studies In Patients With Cancer
- Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
- Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
- Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
- Monocyte Phenotypic and Functional Differences
- Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
- NAC to Prevent Cisplatin-induced Hearing Loss
- Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
- Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
- Olaparib With Ceralasertib in Recurrent Osteosarcoma
- Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
- Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
- Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
- Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival
- Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
- Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
- Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
- Pain and Impact of Chronic Pain on Function After Total Knee Replacements
- Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma
- Pediatric PET/MR Image Registry
- Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors
- Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements.
- Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
- Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
- Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
- Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
- Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
- Phase II Study of Intravenous Rexin-G in Osteosarcoma
- Phase II Trial for the Treatment of Relapsed Osteosarcoma
- Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
- Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
- Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas
- Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
- Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
- Proteomics Research of Osteosarcoma
- Pulmonary Resectable Metastases of Osteosarcoma With Apatinib and CHemotherapy
- Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery: a Long-term Follow-up Study
- Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
- Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
- Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
- Regorafenib in Patients With Refractory Primary Bone Tumors
- Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
- Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
- SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
- Sorafenib in Relapsed High Grade Osteosarcoma
- Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
- Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
- Study of Blood Samples From Patients With Osteosarcoma
- Study of CRX100 in Patients With Advanced Solid Tumors
- Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma
- Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
- Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
- Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
- Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
- Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
- Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
- Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
- The Impact of Cancer on the Physical and Psychosocial Well-being Among Childhood Osteosarcoma Survivors
- The Osteosarcoma Biobank in Peking University People’s Hospital
- The Prognostic Value of Serum Biomarkers in Osteosarcoma
- Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
- Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma
- Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
- Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma
- Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
- ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
- Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
- Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
- Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma
- Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children
- Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
- Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
- Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
- Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
- Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing’s Family of Tumors
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
- Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
- Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
- Effect of Anti CD20 in Pemphigus Desease
- European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
- Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders
- Identification of Vulnerability Factors in the Course of Pemphigus Patients
- Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
- Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
- Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
- Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
- The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
- Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
- Validation of 5-Point Investigator Global Assessments for Pemphigus
- Wound Dressings for Pemphigus and Pemphigoid
- A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
- A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
- A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris
- A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
- A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
- A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)
- A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
- Autoimmune Blistering Diseases Study
- Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
- Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
- Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
- Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
- Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
- Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid
- Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus
- Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
- Prospective Analysis of the Th17 Cellular Response in Pemphigus Vulgaris Patients
- Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
- Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity
- Safety Study of PI-0824 to Treat Pemphigus Vulgaris
- Serum IL-21 Levels in Patients With Pemphigus Vulgaris
- Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
- Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
- Use of KC706 for the Treatment of Pemphigus Vulgaris
- Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure
- Effect of a Parenteral Emulsion With Omega3 on PPHN
- Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
- IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
- Milrinone in Congenital Diaphragmatic Hernia
- N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension
- Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
- Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn
- NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn
- Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension
- Persistent Pulmonary Hypertension of the Newborn
- Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study
- Pharmacokinetics of Sildenafil in Premature Infants
- Plethismographic Perfusion Index in Neonates
- Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN
- Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
- PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
- Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
- Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
- The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
- Cancer of the Pancreas Screening Study (CAPS 3)
- Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
- Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
- Hereditary Colorectal and Associated Tumor Registry Study
- Pancreatic Cancer Early Detection Program
- Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
- Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
- Registry of Subjects at Risk of Pancreatic Cancer
- Study of Accurate Diagnosis and Treatment of Peutz-Jeghers Syndrome
- Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
- A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
- AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
- An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
- Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
- Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome
- Growth Hormone Treatment in Children With Phelan McDermid Syndrome
- Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
- Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
- Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
- Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
- Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.
- A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU
- A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
- A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
- A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects
- A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302
- A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
- A Pilot Study on Diurnal Variation
- A Prospective Clinical Study of Phenylketonuria (PKU)
- A Study of PTC923 in Participants With Phenylketonuria
- A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
- AAV Gene Therapy Study for Subjects With PKU
- Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU)
- An Observational, Cross-sectional Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD).
- An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
- Behavioral Effects of Kuvan in Children With Mild Phenylketonuria
- BH4 Responsiveness in PAH Deficiency PKU Patients
- Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia
- Body Composition, Energy Intake and Expenditure in People With Phenylketonuria
- Bone Mineral Density in Adults With Hyperphenylalaninemia
- Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
- Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients
- Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria
- Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
- Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development.
- Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU
- Effects of Kuvan on Melatonin Secretion
- Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
- Efficacy and Safety of SYNB1618 in Adult Patients With Phenylketonuria
- Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)
- Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
- Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
- Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.
- Evaluation of PKU Explore
- Evaluation of PKU Explore France
- Evaluation of PKU Express Plus
- Evaluation of PKU Sphere
- Evaluation of PKU Sphere in Italy
- Evaluation of PKU Sphere Liquid
- Evaluation of PKU Start
- First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
- Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy
- Follow-up of Adult Phenylketonuria (PKU) Patients
- Gene Therapy Clinical Study in Adult PKU
- GMP Drink for PKU Study
- Impact of Fruit and Vegetables in PKU
- Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis
- Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
- Kuvan® in Phenylketonuria Patients Less Than 4 Years Old
- Kuvan®’s Effect on the Cognition of Children With Phenylketonuria
- Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.
- Liver Cell Transplant for Phenylketonuria
- Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
- Long-Term Follow Up Study of Subjects Previously Administered HMI 102
- Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years – Study on Phenylalanine Tolerance and Safety
- Market Research – Acceptability Study for a New PKU Protein Substitute
- Market Research – Acceptability Trial for a New PKU Amino Acid Based Protein Substitute
- Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
- Moderate Intensity Exercise and Phenylketonuria
- MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
- Natural History Clinical Study in Adult PKU
- Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
- Nutrition Status of Adults Treated With Pegvaliase
- Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
- Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
- Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
- Nutritional Status in Phenylketonuria
- Observational Study of Endothelial Dysfunction in Phenylketonuria
- PANDA: PKU Amino Acid Evaluation
- Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
- Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)
- Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
- Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria
- Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
- Phenylalanine and Its Impact on Cognition
- Phenylketonuria, Oxidative Stress, and BH4
- PKU Low Calorie Drink Study
- PKU Skin Stripping
- PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
- Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
- Protein Requirements in Adults With Phenylketonuria (PKU)
- Protein Requirements in Children With Phenylketonuria (PKU)
- Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria
- Remote Neurocognitive and Psychological Assessment in PKU
- Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
- Response to Phenylketonuria to Tetrahydrobiopterin (BH4)
- Safety and Efficacy of HMI-103, a Gene Editing Development Candidate in Adults With Classical PKU Due to PAH Deficiency
- Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
- Safety and Tolerability of RTX-134 in Adults With Phenylketonuria
- Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria
- Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
- Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
- Sapropterin Expanded Access Program
- Sapropterin in Individuals With Phenylketonuria
- Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
- Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria
- Simple Breath Test to Examine Phenylalanine Metabolism
- Simplified Diet Approach in Phenylketonuria
- SNAP: Study Nutrients in Adult PKU
- Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With Phenylketonuria
- Study of BH4, a New and Simple Treatment of Mild PKU
- Study of Low-grade Systemic Inflammation in Adult Patients With Phenylketonuria
- Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006
- Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
- Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria
- Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors
- Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria
- Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
- Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels
- Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
- Testing of Four Home Phenylalanine Monitoring Prototype Devices
- The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
- The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study
- The Early History of Universal Screening for Metabolic Disorders
- The Effect of Nursing Empowerment Program
- The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
- The Effectiveness of Kuvan in Amish PKU Patients
- The Effects of CGMP in Children and Adults With PKU
- The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
- 131MIBG to Treat Malignant Pheochromocytoma
- 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
- A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
- A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
- A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
- A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
- A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
- Blood Sampling for Neurochemical and Genetic Testing
- Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma
- Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation
- Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
- Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
- Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
- Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma
- Diagnosis and Treatment of Pheochromocytoma
- Diagnosis of Pheochromocytoma
- Dosimetry Guided PRRT With 177Lu-DOTATATE in Children
- Dovitinib in Neuroendocrine Tumors
- Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue
- Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study
- Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
- Expanded Access Protocol Using 131I-MIBG
- Expanded Access Protocol Using 131I-MIBG Therapy for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
- Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers
- I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
- In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
- Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT)
- Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
- Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
- Metanephrines in Obstructive Sleep Apnoea
- Multicenter Pheochromocytoma and Paraganglioma Evaluation
- Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma
- Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
- Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma
- Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
- Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET)
- Phenoxybenzamine Versus Doxazosin in PCC Patients
- Pheochromocytoma and Hemodynamic Instability
- Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
- Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
- Preoperative Alpha Blockade for Pheochromocytoma
- Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions
- RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid
- Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
- Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection – Systematic Review and Meta-analysis
- Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma
- Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
- Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
- Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
- Surgeon-Anesthesiologist Collaboration
- Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
- The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
- the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma
- ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
- A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy
- A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
- A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
- A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy
- Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint
- Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy
- Effect of Valproic Acid Concentration on Photic Response
- Photosensitivity Proof of Concept Trial
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).